These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18975928)

  • 1. Synthesis and biological evaluation of a series of liver-selective phosphonic acid thyroid hormone receptor agonists and their prodrugs.
    Boyer SH; Jiang H; Jacintho JD; Reddy MV; Li H; Li W; Godwin JL; Schulz WG; Cable EE; Hou J; Wu R; Fujitaki JM; Hecker SJ; Erion MD
    J Med Chem; 2008 Nov; 51(22):7075-93. PubMed ID: 18975928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.
    Erion MD; Cable EE; Ito BR; Jiang H; Fujitaki JM; Finn PD; Zhang BH; Hou J; Boyer SH; van Poelje PD; Linemeyer DL
    Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15490-5. PubMed ID: 17878314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
    Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
    J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical pharmacokinetics of a HepDirect prodrug of a novel phosphonate-containing thyroid hormone receptor agonist.
    Fujitaki JM; Cable EE; Ito BR; Zhang BH; Hou J; Yang C; Bullough DA; Ferrero JL; van Poelje PD; Linemeyer DL; Erion MD
    Drug Metab Dispos; 2008 Nov; 36(11):2393-403. PubMed ID: 18703645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of phosphonic diamide prodrugs and their use for the oral delivery of a series of fructose 1,6-bisphosphatase inhibitors.
    Dang Q; Kasibhatla SR; Jiang T; Fan K; Liu Y; Taplin F; Schulz W; Cashion DK; Reddy KR; van Poelje PD; Fujitaki JM; Potter SC; Erion MD
    J Med Chem; 2008 Jul; 51(14):4331-9. PubMed ID: 18570362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a series of phosphonic acid-containing thiazoles and orally bioavailable diamide prodrugs that lower glucose in diabetic animals through inhibition of fructose-1,6-bisphosphatase.
    Dang Q; Liu Y; Cashion DK; Kasibhatla SR; Jiang T; Taplin F; Jacintho JD; Li H; Sun Z; Fan Y; DaRe J; Tian F; Li W; Gibson T; Lemus R; van Poelje PD; Potter SC; Erion MD
    J Med Chem; 2011 Jan; 54(1):153-65. PubMed ID: 21126019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia.
    Shiohara H; Nakamura T; Kikuchi N; Ozawa T; Nagano R; Matsuzawa A; Ohnota H; Miyamoto T; Ichikawa K; Hashizume K
    Bioorg Med Chem; 2012 Jun; 20(11):3622-34. PubMed ID: 22542282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver-targeted prodrugs of 2'-C-methyladenosine for therapy of hepatitis C virus infection.
    Hecker SJ; Reddy KR; van Poelje PD; Sun Z; Huang W; Varkhedkar V; Reddy MV; Fujitaki JM; Olsen DB; Koeplinger KA; Boyer SH; Linemeyer DL; MacCoss M; Erion MD
    J Med Chem; 2007 Aug; 50(16):3891-6. PubMed ID: 17636948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Design, synthesis and anti-HBV activity of L-amino acid ester prodrugs of acyclic nucleoside phosphonates].
    Fu XZ; Jiang SH; Yang YS; Ji RY
    Yao Xue Xue Bao; 2008 May; 43(5):495-503. PubMed ID: 18717337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of dually branched 5'-norcarbocyclic adenosine phosphonodiester analogue as a new anti-HIV prodrug.
    Oh CH; Liu LJ; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2010 Oct; 29(10):721-33. PubMed ID: 20924954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
    Dang Q; Kasibhatla SR; Reddy KR; Jiang T; Reddy MR; Potter SC; Fujitaki JM; van Poelje PD; Huang J; Lipscomb WN; Erion MD
    J Am Chem Soc; 2007 Dec; 129(50):15491-502. PubMed ID: 18041834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and characterization of a series of cytochrome P(450) 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liver.
    Erion MD; Reddy KR; Boyer SH; Matelich MC; Gomez-Galeno J; Lemus RH; Ugarkar BG; Colby TJ; Schanzer J; Van Poelje PD
    J Am Chem Soc; 2004 Apr; 126(16):5154-63. PubMed ID: 15099098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemic prodrugs of 4-(2,2-dimethyl-1-oxopropyl)benzoic acid.
    Aicher TD; Bebernitz GR; Bell PA; Brand LJ; Dain JG; Deems R; Fillers WS; Foley JE; Knorr DC; Nadelson J; Otero DA; Simpson R; Strohschein RJ; Young DA
    J Med Chem; 1999 Jan; 42(1):153-63. PubMed ID: 9888840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of potent and orally active tricyclic-based FBPase inhibitors.
    Tsukada T; Kanno O; Yamane T; Tanaka J; Yoshida T; Okuno A; Shiiki T; Takahashi M; Nishi T
    Bioorg Med Chem; 2010 Jul; 18(14):5346-51. PubMed ID: 20542703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine.
    Li YH; Li Y; Yang P; Kong WJ; You XF; Ren G; Deng HB; Wang YM; Wang YX; Jiang JD; Song DQ
    Bioorg Med Chem; 2010 Sep; 18(17):6422-8. PubMed ID: 20673726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fructose-1,6-bisphosphatase Inhibitors. 2. Design, synthesis, and structure-activity relationship of a series of phosphonic acid containing benzimidazoles that function as 5'-adenosinemonophosphate (AMP) mimics.
    Dang Q; Kasibhatla SR; Xiao W; Liu Y; Dare J; Taplin F; Reddy KR; Scarlato GR; Gibson T; van Poelje PD; Potter SC; Erion MD
    J Med Chem; 2010 Jan; 53(1):441-51. PubMed ID: 20055427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodrugs of perzinfotel with improved oral bioavailability.
    Baudy RB; Butera JA; Abou-Gharbia MA; Chen H; Harrison B; Jain U; Magolda R; Sze JY; Brandt MR; Cummons TA; Kowal D; Pangalos MN; Zupan B; Hoffmann M; May M; Mugford C; Kennedy J; Childers WE
    J Med Chem; 2009 Feb; 52(3):771-8. PubMed ID: 19146418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of brivanib alaninate ((S)-((R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor (BMS-540215).
    Cai ZW; Zhang Y; Borzilleri RM; Qian L; Barbosa S; Wei D; Zheng X; Wu L; Fan J; Shi Z; Wautlet BS; Mortillo S; Jeyaseelan R; Kukral DW; Kamath A; Marathe P; D'Arienzo C; Derbin G; Barrish JC; Robl JA; Hunt JT; Lombardo LJ; Fargnoli J; Bhide RS
    J Med Chem; 2008 Mar; 51(6):1976-80. PubMed ID: 18288793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and anti-HIV activity of 4'-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitors.
    Boojamra CG; Parrish JP; Sperandio D; Gao Y; Petrakovsky OV; Lee SK; Markevitch DY; Vela JE; Laflamme G; Chen JM; Ray AS; Barron AC; Sparacino ML; Desai MC; Kim CU; Cihlar T; Mackman RL
    Bioorg Med Chem; 2009 Feb; 17(4):1739-46. PubMed ID: 19179082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and sustained-release property of 1,3-cyclic propanyl phosphate ester of 18β-glycyrrhetinic acid.
    Sun W; Peng W; Li G; Jiang T
    Chem Biol Drug Des; 2011 Mar; 77(3):206-11. PubMed ID: 21244638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.